SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001513162-19-000205
Filing Date
2019-09-12
Accepted
2019-09-12 16:30:18
Documents
1
Period of Report
2019-09-12
Effectiveness Date
2019-09-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 442290
  Complete submission text file 0001513162-19-000205.txt   443504
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: DEF 14A | Act: 34 | File No.: 001-37492 | Film No.: 191090690
SIC: 8071 Services-Medical Laboratories